AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
CSL (ASX:CSL) and Pro Medicus (ASX:PME): Healthcare Innovators Shaping the ASX 100 Landscape
July 16, 2025 08:28 PM AEST| By Team Kalkine MediaHighlights,CSL operates across plasma, vaccines, and nephrology care,Pro Medicus leads in radiology software and global healthcare IT,Both companies contribute to innovation in medical technology,Australia’s healthcare sector remains a vital pillar o...
ResMed (ASX:RMD): ASX 100 Healthcare Leader Signals Solid Growth in 2025
July 16, 2025 07:31 PM AEST| By Team Kalkine MediaHighlights,ResMed (RMD) maintains upward revenue and profit momentum,Healthy balance sheet supports long-term operational stability,SaaS integration strengthens out-of-hospital healthcare delivery,ResMed (RMD), a dual-listed medical technology compan...
Mesoblast (ASX:MSB) Insider Confidence Stands Out Amid ASX 300 Landscape
July 16, 2025 05:15 PM AEST| By Team Kalkine MediaHighlights,Insider transactions reflect long-term confidence,Substantial ownership by insiders in focus,ASX 300 biotech sees notable internal support,Mesoblast, a key player in the biotechnology space and part of the,ASX 300,, has recently attracted...
Imugene (ASX:IMU) Secures Capital to Accelerate Clinical Trials for Innovative CAR-T Therapy
July 16, 2025 05:07 PM AEST| By Team Kalkine MediaHighlights,Imugene advances azer-cel therapy for difficult lymphoma cases,Capital raised supports pivotal Phase 2 clinical trial,Positive early results boost development momentum,Imugene (ASX:IMU), a biotech company working on cutting-edge cancer imm...
Prescient Therapeutics (ASX:PTX) Begins US Enrolment for PTX-100 Trial | ASX 300
July 16, 2025 04:24 PM AEST| By Team Kalkine MediaHighlights,Prescient Therapeutics launches first US site at VCU Massey for Phase 2a PTX-100 trial,The global study now includes patients across both US and Australia,PTX-100, a GGT-1 inhibitor, is the only compound of its class currently in clinical...
Lumos Diagnostics (ASX:LDX) Secures Major US Deal for FebriDx® | All Ordinaries
July 16, 2025 04:21 PM AEST| By Team Kalkine MediaHighlights,Lumos Diagnostics signs exclusive multi-year US distribution deal with PHASE Scientific,Agreement includes milestone payments tied to regulatory progress for FebriDx®,CLIA waiver study nearing completion with submission expected in coming...
Tryptamine Therapeutics Expands Psilocin Clinical Team Ahead of TRP-8803 Trial | All Ordinaries
July 16, 2025 04:12 PM AEST| By Team Kalkine MediaHighlights,Tryptamine Therapeutics strengthens TRP-8803 program with two senior appointments,Australian-based team structure expected to enhance operational efficiency,Preparations underway for first-ever Binge Eating Disorder trial with Swinburne Un...
Tryptamine Therapeutics Advances Psychedelic Research with Key Appointments | ASX200 Clinical Innovation Update
July 16, 2025 01:59 PM AEST| By Team Kalkine MediaHighlights,Tryptamine Therapeutics expands its clinical team with top experts,Focus intensifies on innovative psilocin-based treatment development,Preparations underway for groundbreaking binge eating disorder trial,Tryptamine Therapeutics (ASX:TYP)...
Imugene Bolsters Clinical Trial Funding with Capital Raise | ASX200 Pipeline Progress
July 16, 2025 01:48 PM AEST| By Team Kalkine MediaHighlights,Imugene strengthens funding through placement and SPP,Focus remains on advancing the azer-cel clinical trial,Strategic financial planning supports long-term R&D efforts,Imugene (ASX:IMU), a clinical-stage immuno-oncology company, has taken...
Prescient Therapeutics Extends SPP Timeline | ASX 300 Biotech Eyes PTX-100 Progress
July 15, 2025 04:09 PM AEST| By Team Kalkine MediaHighlights,Prescient Therapeutics extends Share Purchase Plan deadline,Funds allocated to advance Phase 2 trial for oncology candidate PTX-100,Broader pipeline includes cell therapy enhancements and modular CAR-T platform,Prescient Therapeutics Ltd (...
Compumedics (ASX:CMP) Marks Major Turnaround with Robust Revenue Growth and Strategic Vision
July 15, 2025 11:39 AM AEST| By Team Kalkine MediaHighlights,Compumedics records robust growth across Sleep & Neurology segments,SaaS platforms show expanding global traction,Strategic focus aligned with,high-margin,recurring revenue model,Compumedics (ASX:CMP), a notable medical technology company,...
Compumedics Signals Strategic Growth Shift with Record Results: Momentum Builds Across SaaS and Sleep Diagnostics
July 15, 2025 10:12 AM AEST| By Team Kalkine MediaHighlights,Compumedics shifts into a new growth phase with innovation-led momentum,Sleep diagnostics and SaaS platforms,emerge,as key revenue drivers,Expansion in global neurotech markets supports long-term growth strategy,Compumedics (ASX:CMP) is st...
Imugene (ASX:IMU) Progresses Azer-cel Trial with Promising Data Amid ASX200 Landscape
July 14, 2025 11:43 AM AEST| By Team Kalkine MediaHighlights,Positive data drives Imugene’s expansion of trial scope,Azer-cel shows strong promise in relapsed lymphoma cases,Regulatory progress signals broader therapeutic potential,Imugene (ASX:IMU), a clinical-stage immuno-oncology company, has rep...
Imugene’s Azer-cel Advances in Phase 1b Trial for DLBCL Amidst Strong Momentum | ASX200 Share Price Insight
July 14, 2025 10:42 AM AEST| By Team Kalkine MediaHighlights,Azer-cel shows encouraging responses in advanced DLBCL trial,FDA meeting planned for next steps in pivotal study,Trial expansion to include broader B-cell lymphoma subtypes,Imugene Ltd (ASX:IMU) has released positive data from its Phase 1b...
Ramsay Health Care’s Momentum vs Fundamentals: ASX 100 Share Price Rally in Focus
July 11, 2025 05:44 PM AEST| By Team Kalkine MediaHighlights,Ramsay Health Care shows recent share price strength,Financial indicators raise key concerns,ROE reveals efficiency pressure,Ramsay Health Care (ASX:RHC), a prominent name in the healthcare sector, has experienced a noticeable upward movem...
Is Sonic Healthcare (ASX:SHL) Losing Its Momentum in the ASX 100 Growth Race?
July 11, 2025 05:22 PM AEST| By Team Kalkine MediaHighlights,Sonic Healthcare’s ROCE trend shows limited improvement,Capital deployment not delivering stronger efficiency gains,Growth trajectory appears to be slowing despite expansion efforts,Sonic Healthcare (ASX:SHL) has built a reputation as one...
Orthocell Hits US Breakthrough, Boosts ASX 200 Biotech Momentum
July 11, 2025 04:01 PM AEST| By Team Kalkine MediaHighlights,Orthocell Ltd confirms first commercial sales of Remplir™ in the US,FDA clearance achieved earlier this year followed by initial surgical usage,Company focused on expanding its US footprint through strategic distribution,Biotech company Or...
Telix Pharmaceuticals (ASX:TLX) Eyes US Milestone as Zircaix Decision Nears | ASX 200
July 11, 2025 03:48 PM AEST| By Team Kalkine MediaHighlights,Telix Pharmaceuticals (ASX:TLX) awaits US FDA decision on Zircaix radiopharmaceutical,Zircaix aims to be the first imaging agent labeled for renal mass detection,Market size estimates highlight strong near-term potential for commercialisat...
ASX Top 300 Healthcare Focus: Can These Two Biotech Shares Rebound Strongly?
July 10, 2025 05:40 PM AEST| By Team Kalkine MediaHighlights,Clinical progress sparks attention for key biotech firms,U.S. regulatory path sets milestone for one heart device innovator,Radiopharmaceutical developments may unlock commercial,Two healthcare companies on the ASX have continued to genera...
Mach7 Technologies (ASX:M7T) Updates FY25 Outlook with Strategic Moves and Share Buyback
July 10, 2025 05:01 PM AEST| By Team Kalkine MediaHighlights,FY25 revenue guidance reaffirmed amid recurring revenue growth,Ongoing share buyback signals confidence in long-term value,Debt-free position with strong cash flow forecast for FY25,Mach7 Technologies (ASX:M7T),has shared its latest FY25 b...
Advertise your brand on Kalkine Media